Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. for allegedly misleading investors regarding its accounts receivable practices during the Class Period from July 18, 2024, to November 12, 2025 [1][3]. Group 1: Lawsuit Details - The lawsuit claims that Ardent misrepresented its process for determining the collectability of accounts receivable, stating it relied on detailed historical reviews, while in reality, it used a 180-day cliff method for reserving accounts [3]. - On November 12, 2025, Ardent announced a $43 million reduction in revenue due to changes in accounting estimates for accounts receivable collectability and a $54 million increase in professional liability reserves, leading to a significant drop in share price by approximately 33.8% [4]. Group 2: Legal Process - The lead plaintiff deadline for the class action is set for March 9, 2026, and applications filed after this date will not be considered [2]. - The lead plaintiff plays a crucial role in overseeing the litigation and can influence key decisions, including litigation strategy and settlement [2].
ARDT INVESTOR ALERT: Contact Kirby McInerney LLP About Securities Class Action Lawsuit On Behalf of Ardent Health, Inc. Investors